Navigation Links
FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency
Date:10/1/2009

facilities time to learn about the changes and to make adjustments to their pharmacy procedures and dosing practices, according to John Jenkins, M.D. director of the Office of New Drugs in the FDA's Center for Drug Evaluation and Research.

"Although the FDA-approved labeling for heparin has not changed, including the recommended doses, it is essential that health care professionals be aware of the potential difference in potency between the old and new vials of heparin when administering the drug," said Jenkins.

Four companies market heparin in the United States. APP, the largest manufacturer, markets heparin in vials; Hospira markets heparin in intravenous bags, vials, and syringes; Baxter markets heparin in intravenous bags, and B. Braun markets heparin in intravenous bags. The FDA has asked that all manufacturers identify their new products to help pharmacies and health care professionals differentiate it from the former product.

Prescription and over-the-counter medicines available in the United States must generally meet USP's public standards, when such standards exist. The revised standards for heparin are contained in a new USP monograph.

The monograph was revised, in part, in response to a 2007- 2008 incident of heparin contamination involving a manufacturing step in China. The contaminated heparin was associated with deaths and other adverse events in the United States. The monograph was changed to include a test for the contaminant.

For more information

FDA Alert to Health Care Professionals

http://www.fda.gov//Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm184502.htm

USP Heparin Information

http://www.usp.org/hottopics/heparin.html

'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
2. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
3. Real-World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin (UFH)
4. Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients
5. Interface Biologics Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings
6. ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI
7. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
8. WaveSense Diabetes Products Safe from Maltose Inaccuracy Risks
9. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
10. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
11. Processed Tomato Products May Protect Against Inflammation, According to a Study Presented at the Experimental Biology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Siemens Healthcare today announced a ... to help healthcare providers pursue ... within the HITECH provision of the American ... Featuring zero-percent interest terms for qualified customers, ... payments associated with their technology investment while ...
(Date:12/16/2009)... -- Biovista Inc.,today announced that it was awarded ... the 2009 New England Venture Summit, held on ... cutting edge private companies,driving the future of innovation, ... other privately held companies that play a leading ... Clean-tech sectors. , "We ...
(Date:12/16/2009)... Avantium announced the,appointment of Gunnar Staaf as ... Staaf previously worked at Serentis Ltd, Astellas ... a range of commercial and executive,positions. The ... plan to,spin-out its pharmaceutical business. The company ... on its offering of proprietary,crystallization services and ...
Breaking Medicine Technology:Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 2Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 3Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 4Biovista Inc. Named Top Innovator in Life Sciences 2Avantium Appoints Gunnar Staaf as CEO Pharma 2Marteks lifesDHA 28TM 29 Featured in New Nutrioli DHA Cooking Oil from Ragasa 57854 1Marteks lifesDHA 28TM 29 Featured in New Nutrioli DHA Cooking Oil from Ragasa 57854 2Marteks lifesDHA 28TM 29 Featured in New Nutrioli DHA Cooking Oil from Ragasa 57854 3Many Teens Circumvent Tanning Bed Laws 57851 1Many Teens Circumvent Tanning Bed Laws 57851 2Many Teens Circumvent Tanning Bed Laws 57851 3The doctor can understand you now 57848 1The doctor can understand you now 57848 2The doctor can understand you now 57848 3
... Infectious Disease Specialist, also available as,Expert Resource, FLUSHING, N.Y., Oct. 30 The following ... A special briefing on methicillin-resistant Staphylococcus ... James Rahal, M.D., and a ... specialists from New York Hospital Queens will address the ...
... Oct. 30 Leading researchers,will present 68 ... (peginterferon alfa-2b) and REBETOL(R),(ribavirin, USP) combination therapy, ... of chronic hepatitis C, at the 58th ... (AASLD) Annual Meeting in Boston, Nov. 2-6. ...
Other Medicine Technology:Hospital to Hold MRSA Briefing for Media and Community Leaders 2Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 7
(Date:12/16/2009)... Cost-Effective Care , ... Washington, D.C. (Vocus) December 16, ... ways to rein in runaway costs while providing care to all ... the ongoing discussion includes how to ensure patients equal access to ... (MDs) or osteopathy (DOs). In both the House and Senate ...
(Date:12/16/2009)... been found, , , WEDNESDAY, Dec. 16 (HealthDay News) -- ... food poisoning and the stomach pain and diarrhea that ... urinary tract infections. , Researchers have found the same ... restaurants and in women with the infections. , ... to the women through the food they ate, although ...
(Date:12/16/2009)... NSRTSM is found very effective in the alleviation of symptoms ... chronic fatigue and a wide array of skin conditions. ... holistic therapy including over 50 branded BioVeda Health and Wellness ... ... December 14, 2009 -- BioVeda Health and Wellness Centers, LLC. ...
(Date:12/16/2009)... not be determining factor for use, expert says, , , ... heart failure are much less likely to die when ... study. , The study included 4,685 people, ages 65 ... had a left ventricular fraction (a measure of the ... During a three-year period, those who were treated with ...
(Date:12/16/2009)... also at all-time low, government report shows, , , WEDNESDAY, ... the United States has reached almost 78 years, a ... birth in 2007, women can expect to live to ... according to the report from the U.S. Centers for ... Americans can expect to live longer than their parents, ...
Breaking Medicine News(10 mins):Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5Health News:Implanted Defibrillator Might Extend Life 2Health News: Life Expectancy in U.S. Hits New High 2Health News: Life Expectancy in U.S. Hits New High 3
... Physical Therapy, one of,Los Angeles, most innovative, ... services, is the first and,only physical therapy ... G-Trainer anti-gravity treadmill for athletic training and ... facilities using the G-Trainer have,noted faster recovery ...
... 2008 --- A study conducted by a team of ... demonstrates that CT (computed tomography) perfusion imaging - a ... most hospitals - may dramatically improve fast and accurate ... and helping avoid potentially life-threatening complications of "clot buster" ...
... YORK, Oct. 29 A new report released,today by ... Democracy,finds that many of this country,s dangerous government-approved drugs ... these products,were removed or made safer only after women ... BITTEREST PILL -- How Drug Companies,Fail To Protect Women ...
... 29 Morria Biopharmaceuticals Plc, a,biopharmaceutical company ... announced today the preliminary results from its,recently ... in a nasal aerosol,formulation, in 105 patients ... multi-dose, double-blind, placebo-controlled study,included Rhinocort(R) as the ...
... in the digestive tract make occasional digestive issues more likely. In ... every year, and as many as 40% of older, boomer-aged adults ... has launched the answer for baby boomers wondering what happened to ... ...
... cancer tissues was detected by immunohistochemistry (IHC), Western ... by Its correlation Western blotting and RT-PCR. Livin ... increasing with tumor progression. Expression of Livin and ... In the fourth clinical stage, expression of Livin ...
Other Medicine News:Health News:Evolution Physical Therapy First Clinic in Southern California to Introduce NASA-Designed Anti-Gravity Treadmill for Public Use 2Health News:Evolution Physical Therapy First Clinic in Southern California to Introduce NASA-Designed Anti-Gravity Treadmill for Public Use 3Health News:WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke 2Health News:WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke 3Health News:New Report Shows How Drug Industry Immunity Would Endanger Women 2Health News:Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis 2Health News: What Boomers Need to Know About Digestion; Enzymatic Therapy's CompleteGest1 Renew targets special digestive issues 2Health News:A potential targets for the prevention or treatment of esophageal carcinoma 2
... whisper quiet, compact system is perfect for ... accurate and cost effective microhematocrits are required. ... CritSpin System offers a range of important ... packing - Meets NCCLS standards - Read ...
... personal Microcentrifuge with swinging bucket rotor. ,The ... centrifuge with a swinging bucket rotor and ... ideal for a variety of clinical, biomedical, ... pellet formation of a "swinging bucket centrifuge ...
... a unique closed system for performing fast, ... CenSlide 2000 system is microprocessor controlled to ... speed for one minute. At the end ... distributed evenly across the viewing area for ...
... internal drainage from the ureteropelvic ... sterile in peel-open packages. Intended ... evaluation is advised; polyurethane, C-Flex, ... remain indwelling more than six ...
Medicine Products: